GlassScriptPhysician profile
Morgan Popovich
NPI 1225611189
$11,721.48
in general payments reported to CMS, 2019-2025
36 companies · $2,993 in 2025
The $2,993 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $419 · 2022: $2,511 · 2023: $2,904 · 2024: $2,894 · 2025: $2,993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,315 · Education: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,315.35 |
| Education | $475.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,085.32 | 2021-2025 | Enbrel, Evenity, Otezla |
| Janssen Biotech, INC. | $1,533.29 | 2022-2025 | Tremfya, Simponi Aria |
| Mallinckrodt Hospital Products INC. | $1,376.07 | 2021-2025 | Acthar |
| Abbvie INC. | $1,168.93 | 2021-2025 | |
| Lilly USA, LLC | $1,088.86 | 2021-2025 | Taltz, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $638.80 | 2021-2025 | Saphnelo, Airsupra, Breztri |
| Pfizer INC. | $545.39 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $521.07 | 2021-2025 | |
| Ucb, INC. | $509.90 | 2021-2025 | Cimzia, Bimzelx |
| Glaxosmithkline, LLC. | $293.90 | 2022-2025 | Benlysta |
| Radius Health, INC. | $238.59 | 2021-2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $227.75 | 2023-2025 | Spevigo, Cyltezo |
| Idorsia Pharmaceuticals US INC | $181.27 | 2022-2024 | Quviviq |
| Alexion Pharmaceuticals, INC. | $175.73 | 2022-2025 | Strensiq, Ultomiris |
| Organon LLC | $167.83 | 2023-2025 | Hadlima, Renflexis |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $115.92 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Fresenius Kabi USA, LLC | $95.83 | 2023-2024 | Idacio |
| Genentech USA, INC. | $92.25 | 2023-2025 | Actemra, Ocrevus Zunovo |
| Janssen Scientific Affairs, LLC | $78.00 | 2022 | |
| Merck Sharp & Dohme LLC | $66.04 | 2024-2025 | Capvaxive, Gardasil 9 |
| Ibsa Pharma INC. | $65.86 | 2023-2024 | Tirosint, Licart, Tirosint |
| Sandoz INC. | $64.03 | 2023-2024 | Hyrimoz |
| Esperion Therapeutics, INC. | $48.93 | 2024-2025 | Nexletol |
| Pacira Therapeutics, INC. | $48.53 | 2021 | |
| Ani Pharmaceuticals, INC. | $39.88 | 2022-2024 | Purified Cortrophin Gel |
| Aurinia Pharma U.S., INC. | $39.83 | 2022-2024 | Lupkynis |
| Actelion Pharmaceuticals US, INC. | $30.60 | 2022 | |
| Horizon Therapeutics Plc | $28.98 | 2022-2023 | Krystexxa |
| Eisai INC. | $27.14 | 2023 | |
| Depuy Synthes Sales INC. | $20.41 | 2023 | Monovisc |
| Daiichi Sankyo INC. | $20.31 | 2023 | Injectafer |
| Pacira Pharmaceuticals Incorporated | $20.08 | 2025 | Zilretta, Iovera |
| Scilex Pharmaceuticals INC. | $18.36 | 2025 | |
| Novo Nordisk INC | $17.41 | 2023 | Wegovy |
| Amarin Pharma, INC. | $16.00 | 2021 | |
| Fidia Pharma USA INC. | $14.39 | 2023 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Popovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.